News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

On the left side of the graphic is a caucasian man wearing glasses and a suit. The photo shows him in portrait mode. The right side is blue and has a white logo and text.
News Release

Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.

Read More
A logo on white background
News Release

INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.

Read More
A human hand holds a magnifying glass up to a computer screen. The screen is out of focus but the area under the magnifying glass is crystal clear. It appears to be the website for the FDA.
News Release

Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Shelves of fresh vegetables out for display at a supermarket

Trendspotting: Increasing produce profits comes down to location, location, location

The Produce News, February 26, 2026

Every retailer in every industry is looking to increase profits, perhaps none more so than the grocery channel where margins are razor thin. For grocers, there may be a big opportunity in the produce (and other perishables) aisle.

According to new research in the INFORMS journal Management Science, grocery retailers may not need new technology or behavior change from shoppers to do so. Small operational decisions already under a retailer’s control — including how perishable items are displayed and when (and how much) they’re discounted — can increase profits while also reducing spoilage.

Heads of lettuce in rows in a field

Cyclospora not an easy trace, says supply chain expert

QSR Web, July 29, 2026

As the largest Cyclospora outbreak in U.S. history continues to unfold, restaurant operators are once again facing the reputational fallout of a food safety issue that may have originated long before produce reached their kitchens.

A collection of heads of lettuce

Cyclospora Outbreak Highlights the Science Behind Foodborne Disease Investigations

Infection Control Today, July 28, 2026

When reports of foodborne illness begin appearing across multiple states, identifying the contaminated product is rarely straightforward. Investigators often start with little more than patients describing meals they ate weeks earlier, then painstakingly reconstruct supply chains that can span continents before determining where contamination likely occurred.

A woman in a white lab coat looks to the left. Behind her are shelves and shelves of bottles and small boxes -- pharmaceuticals

Trump has another tariff plan to reshore generic drug production. Will it work?

Supply Chain Dive, August 4, 2026

President Donald Trump is back at it with his tariff threats for pharma, promising massive levies on generic drug imports starting in 2028.

The president’s proposal — which was announced on Truth Social and has yet to be solidified via an official proclamation or notice — is framed as a push to encourage domestic drug manufacturing.

Trump outlined a 100% tariff on generic drugs originating from outside the U.S. starting on Aug. 1, 2028, which would be increased to 200% the following year. 

But the conditions that have long kept generic drug manufacturing out of the U.S. largely haven’t changed and Trump’s most recent plan might only succeed in making drugs more expensive while failing to bring factories stateside, according to Tinglong Dai, the Bernard T. Ferrari professor of business at Johns Hopkins Carey Business School.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine